Fragment-Based Drug Discovery: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
Compounds 1 & 2 exhibited very poor binding affinity for Bcl-xl. The optimization of these two compounds resulted in <scene name='Sandbox_reserved_394/Compound_2/1'>Compound 3</scene>. In order to improve the binding affinity, the carboxylic acid of compound 1 was substituted with an acyl sulfonamide to capitalize on the hydrophilic interaction with the protein. This <scene name='Sandbox_reserved_394/Compound_2/3'>acylsulfonamide portion forms a hydrogen bond with Gly 142</scene> thereby increasing the affinity for Bcl-xl. The substitution of the sulfonamide actually allows the acidic proton to get closer to Gly 142 than it could in the carboxylic acid, which is why it is able to bind stronger to the amino acid. | Compounds 1 & 2 exhibited very poor binding affinity for Bcl-xl. The optimization of these two compounds resulted in <scene name='Sandbox_reserved_394/Compound_2/1'>Compound 3</scene>. In order to improve the binding affinity, the carboxylic acid of compound 1 was substituted with an acyl sulfonamide to capitalize on the hydrophilic interaction with the protein. This <scene name='Sandbox_reserved_394/Compound_2/3'>acylsulfonamide portion forms a hydrogen bond with Gly 142</scene> thereby increasing the affinity for Bcl-xl. The substitution of the sulfonamide actually allows the acidic proton to get closer to Gly 142 than it could in the carboxylic acid, which is why it is able to bind stronger to the amino acid. | ||
Compound 2 was important in identifying the hydrophobicity of binding site 2 but was substituted with a <scene name='Sandbox_reserved_394/Nitro_thio_phenyl_sub/1'>3-nitro-4-(2-phenylthioethyl)aminophenyl group</scene>. This substitution more efficiently binds to site 2 through <scene name='Sandbox_reserved_394/Pi_stacking/ | Compound 2 was important in identifying the hydrophobicity of binding site 2 but was substituted with a <scene name='Sandbox_reserved_394/Nitro_thio_phenyl_sub/1'>3-nitro-4-(2-phenylthioethyl)aminophenyl group</scene>. This substitution more efficiently binds to site 2 through <scene name='Sandbox_reserved_394/Pi_stacking/3'>pi-pi interactions with Phe 101 and Tyr 199</scene>. This idea of using a known ligand to develop another ligand, and eventually drugs, is known as ligand-based drug design. | ||
{| class="wikitable collapsible collapsed" | {| class="wikitable collapsible collapsed" | ||
